4.2 Article

Atrial fibrillation detected with outpatient cardiac rhythm monitoring in patients with ischemic stroke or TIA of undetermined cause

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Use of Prolonged Cardiac Rhythm Monitoring to Identify Atrial Fibrillation After Cryptogenic Stroke

Alexis T. Roy et al.

Summary: This review summarizes the current research on the use of prolonged cardiac monitoring (PCM) for detection of atrial fibrillation (AF) after cryptogenic stroke. While PCM improves AF detection, further research is needed to demonstrate its impact on clinical outcomes. The optimal type, timing, and length of cardiac monitoring after cryptogenic stroke remains unknown. Clinical calculators may help identify which patients would benefit most from PCM. PCM remains an important part of evaluating cryptogenic stroke, as detection of AF allows for anticoagulation initiation.

CURRENT CARDIOLOGY REPORTS (2022)

Article Clinical Neurology

Identification of patients with embolic stroke of undetermined source and low risk of new incident atrial fibrillation: The AF-ESUS score

George Ntaios et al.

Summary: The study developed a scoring system to identify ESUS patients with low risk of new incident atrial fibrillation (AF). The proposed scoring system has high sensitivity and negative predictive value, with patients scoring <= 0 being at low risk of developing new AF during follow-up.

INTERNATIONAL JOURNAL OF STROKE (2021)

Article Medicine, General & Internal

Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease The STROKE-AF Randomized Clinical Trial

Richard A. Bernstein et al.

Summary: The STROKE-AF trial demonstrated that among patients with stroke attributed to large- or small-vessel disease, long-term cardiac monitoring with an insertable cardiac monitor (ICM) detected significantly more cases of atrial fibrillation (AF) over 12 months compared to usual care. However, further research is needed to determine the clinical significance of identifying AF in these patients.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

H. -C. Diener et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Cardiac & Cardiovascular Systems

C2HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study

Yan-Guang Li et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)

Review Cardiac & Cardiovascular Systems

Burden of atrial high-rate episodes and risk of stroke: a systematic review

Steven B. Uittenbogaart et al.

EUROPACE (2018)

Article Medicine, General & Internal

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

R. G. Hart et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Cardiac & Cardiovascular Systems

Complications after implantation of a new-generation insertable cardiac monitor: Results from the LOOP study

Soren Zoga Diederichsen et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Editorial Material Clinical Neurology

Seek and Ye Shall Find Fibrillations

David Z. Rose et al.

STROKE (2016)

Article Medicine, General & Internal

96 hours ECG monitoring for patients with ischemic cryptogenic stroke or transient ischaemic attack

Giorgia Manina et al.

INTERNAL AND EMERGENCY MEDICINE (2014)

Article Medicine, General & Internal

Atrial Fibrillation in Patients with Cryptogenic Stroke

David J. Gladstone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Cryptogenic Stroke and Underlying Atrial Fibrillation

Tommaso Sanna et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)